Briquilimab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Briquilimab, covering 2025-09-16 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials [Phase 2]